1 / 6

Neurostimulation Device Global Market Industry Insights and Forecast To 2027

North America dominates the neurostimulation device market owing to the rising geriatric population, increasing incidences of neurological diseases, enhanced healthcare system and government funding for research and development will propel the growth in the region. The presence of major players and increased investment by amnufacturers for technological devleopemnt of devices will further propel the growth of neurostimulation device market in the region.

Research1
Download Presentation

Neurostimulation Device Global Market Industry Insights and Forecast To 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Neurostimulation Device Market

  2. About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

  3. Global Neurostimulation Device Market The global neurostimulation device market is anticipated to grow at 11.6% CAGR owing to several neurological disorders like Alzheimer’s disease, Parkinson’s disease, epilepsy, and cerebrovascular diseases. The increasing demand for minimally invasive surgeries owing to the rising preference among patients for speedy recovery and shorter hospital stays and increased investment in R&D for neurostimulation devices by manufacturers to produced technologically developed devices will propel the growth of the global neurostimulation market. The rising incidences of health disorders and unhealthy lifestyle habits, implementation of developed technologies like Artificial Intelligence and machine learning will lead to the growth of the smart neuromodulation, thereby aiding patients suffering from brain damage. The COVID-19 pandemic has had an adverse impact on the global neurostimulation market owing to postponement of elective surgeries so as to avoid the spread of infectious diseases. However, the market is anticipated to bounce back with relaxation in movements across various nations.

  4. Global Neurostimulation Device Market Based on product, the spinal cord stimulator segment dominates the market owing to technological development in neurostimulation, rising demand to treat spinal injuries and neuropathic pain will augment the growth of the spinal cord stimulators market. Based on application, the pain management dominates the market owing to the rising prominence of chronic and acute pain disorders among patients suffering from neurological disorders will propel the growth in the market. North America dominates the neurostimulation device market owing to the rising geriatric population, increasing incidences of neurological diseases, enhanced healthcare system and government funding for research and development will propel the growth in the region. The presence of major players and increased investment by amnufacturers for technological devleopemnt of devices will further propel the growth of neurostimulation device market in the region.

  5. Global Neurostimulation Device Market Medtronic plc has acquired Stimgenics, LLC and has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM™) Spinal Cord Stimulation which is a novel and exclusive programming choice to treat patients with chronic pain. The prominent players in the neurostimulation industry include Medtronic, Inc., Boston Scientific Corporation, Cyberonics, Inc., Nevro Corporation, Neurosigma, Inc., Neuropace, Inc., Coclear Ltd., St. Jude Medical Inc., LivaNova PLC, AlevaNeurotherapeutics SA, Synapse Biomedical, Inc., Neuronetics, Inc.

  6. For Sample Report :- https://www.vynzresearch.com/healthcare/neurostimulation-device-market/request-sample www.vynzresearch.com

More Related